22.626 articles found

Striding out with Parkinson disease: evidence-based physical therapy for gait disorders.

Morris ME, Martin CL, Schenkman ML.

Phys Ther · 2009-12-18

DOI: 10.2522/ptj.20090091PMID: 20022998

Large differences in levodopa dose requirement in Parkinson's disease: men use higher doses than women.

Nyholm D, Karlsson E, Lundberg M, Askmark H.

Eur J Neurol · 2009-12-18

DOI: 10.1111/j.1468-1331.2009.02866.xPMID: 20039939

Medicinal preparation containing levodopa and cytidine diphosphate and application thereof in treating parkinson diseases

KE CHEN, WEI HUANG, YUEJUN KE, YALI LI, RULIAN LIU, XUANYI MA, XUHUA MAO, ZHIQIANG MIN, CHUNJIU WU, LIANG XIANG, KUI YANG, HUAILI ZHANG, MINGHONG ZHANG.

· 2009-12-16

Chronic systemic treatment with a high-dose proteasome inhibitor in mice produces akinesia unrelated to nigrostriatal degeneration.

Shin M, Jan C, Jacquard C, Jarraya B, Callebert J, Launay JM, Hantraye P, Remy P, Palfi S, Brouillet E.

Neurobiol Aging · 2009-12-16

DOI: 10.1016/j.neurobiolaging.2009.11.015PMID: 20018410

Direct switch from levodopa/benserazide or levodopa/carbidopa to levodopa/carbidopa/entacapone in Parkinson's disease patients with wearing-off: efficacy, safety and feasibility--an open-label, 6-week study.

Eggert K, Skogar O, Skogar O, Amar K, Luotonen L, Kuoppamäki M, Leinonen M, Nissinen H, Oertel W.

J Neural Transm (Vienna) · 2009-12-15

DOI: 10.1007/s00702-009-0344-4PMID: 20013007

Repetitive transcranial magnetic stimulation (rTMS): a possible novel therapeutic approach to dementia with Lewy bodies.

Liang X, Liu K, Guo L.

Med Hypotheses · 2009-12-14

DOI: 10.1016/j.mehy.2009.11.020PMID: 20006914

Home-based speech treatment for Parkinson's disease delivered remotely: a case report.

Constantinescu GA, Theodoros DG, Russell TG, Ward EC, Wilson SJ, Wootton R.

J Telemed Telecare · 2009-12-11

DOI: 10.1258/jtt.2009.090306PMID: 20008051

Compulsive habits in restless legs syndrome patients under dopaminergic treatment.

Pourcher E, Rémillard S, Cohen H.

J Neurol Sci · 2009-12-06

DOI: 10.1016/j.jns.2009.11.010PMID: 19969309

USE OF ELTOPRAZINE FOR THE TREATMENT OF L-DOPA-INDUCED DYSKINESIA

VALASTRO BARBARA, DEKUNDY ANDRZEJ, TENNIGKEIT FRANK, RUSS HERMANN, FRANKE LUTZ.

· 2009-12-04

METHOD FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

PERRIN STEVEN, VIEIRA FERNANDO, GILL ALAN, LINCECUM JOHN.

· 2009-12-04

Use of eltoprazine for the treatment of L-Dopa-induced dyskinesia

VALASTRO BARBARA DR, DEKUNDY ANDRZEJ DR, TENNIGKEIT FRANK DR, RUSS HERMANN PROF DR, FRANKE LUTZ DR.

· 2009-12-04

ELTOPRAZINE FOR THE TREATMENT OF L-DOPA-INDUCED DYSKINESIA

VALASTRO BARBARA, DEKUNDY ANDRZEJ, TENNIGKEIT FRANK, RUSS HERMANN, FRANKE LUTZ.

· 2009-12-04